[{"id":"e8365d64-b203-4dd6-a740-efc6166c28db","acronym":"","url":"https://clinicaltrials.gov/study/NCT05094206","created_at":"2021-10-26T20:53:07.297Z","updated_at":"2024-07-02T16:35:39.176Z","phase":"Phase 1","brief_title":"CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies","source_id_and_acronym":"NCT05094206","lead_sponsor":"Medical College of Wisconsin","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAR20.19.22 T"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 06/30/2022","start_date":" 06/30/2022","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 02/01/2026","study_completion_date":" 02/01/2026","last_update_posted":"2023-08-23"}]